Matthew C. Stubbs

3.0k total citations · 1 hit paper
45 papers, 1.9k citations indexed

About

Matthew C. Stubbs is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Matthew C. Stubbs has authored 45 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 21 papers in Hematology and 9 papers in Oncology. Recurrent topics in Matthew C. Stubbs's work include Acute Myeloid Leukemia Research (15 papers), Protein Degradation and Inhibitors (15 papers) and Histone Deacetylase Inhibitors Research (10 papers). Matthew C. Stubbs is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Protein Degradation and Inhibitors (15 papers) and Histone Deacetylase Inhibitors Research (10 papers). Matthew C. Stubbs collaborates with scholars based in United States, Netherlands and Tunisia. Matthew C. Stubbs's co-authors include Scott A. Armstrong, Andrei V. Krivtsov, Joerg Faber, D. Gary Gilliland, David Twomey, Jason Levine, Jing Wang, William C. Hahn, Yingzi Wang and Todd R. Golub and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Blood.

In The Last Decade

Matthew C. Stubbs

43 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9

2006 1.0k citations Andrei V. Krivtsov, David Twomey et al. Nature profile →

Peers

Matthew C. Stubbs

HEMAT

ONCOL

IMMUN

Zhaohui Feng United States

Jordan Blum United States

Armando G. Poeppl Canada

Camille Lobry United States

Lara Tickenbrock Germany

Jana Krošl Canada

Bülent Sargin Germany

Aniruddha J. Deshpande United States

John Nip United States

Zhaohui Feng United States

Matthew C. Stubbs

1.5k ×1.1

1.1k ×1.2

HEMAT

425 ×0.8

ONCOL

234 ×0.8

196 ×0.9

IMMUN

Citations per year, relative to Matthew C. Stubbs Matthew C. Stubbs (= 1×) peers Zhaohui Feng

Countries citing papers authored by Matthew C. Stubbs

Since Specialization

Citations

This map shows the geographic impact of Matthew C. Stubbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew C. Stubbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew C. Stubbs more than expected).

Fields of papers citing papers by Matthew C. Stubbs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew C. Stubbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew C. Stubbs. The network helps show where Matthew C. Stubbs may publish in the future.

Co-authorship network of co-authors of Matthew C. Stubbs

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew C. Stubbs. A scholar is included among the top collaborators of Matthew C. Stubbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew C. Stubbs. Matthew C. Stubbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Whiteside, Theresa L., Sarita Sehra, Manti Guha, et al.. (2025). Assessment of CD73 activity in breast cancer-derived small extracellular vesicles: application to monitoring of patients’ responses to immunotherapy. Immuno-Oncology Technology. 26. 101052–101052. 1 indexed citations

Arulkumaran, Nishkantha, Mari Thomas, Matthew C. Stubbs, et al.. (2024). A randomised controlled trial of plasma exchange compared to standard of care in the treatment of severe COVID-19 infection (COVIPLEX). Scientific Reports. 14(1). 16876–16876. 1 indexed citations

Monteith, Andrew J., Haley E. Ramsey, Alexander J. Silver, et al.. (2024). Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia. Cancer Research. 84(7). 1101–1114. 6 indexed citations

Wilson, William C., Andrew L. Young, Eunice S. Wang, et al.. (2024). BIRC5 upregulation enhances DNMT3A-mutant T-ALL cell survival and pathogenesis. PubMed. 1(4). 100040–100040. 1 indexed citations

Ramsey, Haley E., Kristy R. Stengel, Agnieszka E. Gorska, et al.. (2021). Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced Differentiation. Targeted Oncology. 16(5). 663–674. 1 indexed citations

Ramsey, Haley E., Susu Zhang, Maria P. Arrate, et al.. (2020). BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia. Clinical Cancer Research. 27(2). 598–607. 15 indexed citations

Ramsey, Haley E., Qi Liu, Jing Wang, et al.. (2020). Nascent transcript and single-cell RNA-seq analysis defines the mechanism of action of the LSD1 inhibitor INCB059872 in myeloid leukemia. Gene. 752. 144758–144758. 20 indexed citations

Mazzacurati, Lucia, Robert J. Collins, Ling Zhang, et al.. (2019). The pan-PIM inhibitor INCB053914 displays potent synergy in combination with ruxolitinib in models of MPN. Blood Advances. 3(22). 3503–3514. 21 indexed citations

Wilson, Andrew J., Matthew C. Stubbs, Phillip Liu, Bruce Ruggeri, & Dineo Khabele. (2018). The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer. Gynecologic Oncology. 149(3). 575–584. 88 indexed citations

10.

Stubbs, Matthew C., Robert J. Collins, Leslie Hall, et al.. (2017). Abstract 143: Preclinical studies on potential therapeutic combination partners for the potent and selective PI3Kδ inhibitor INCB050465 in DLBCL. Cancer Research. 77(13_Supplement). 143–143. 1 indexed citations

11.

Stubbs, Matthew C., Won-Il Kim, Tina Davis, et al.. (2015). Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL. Clinical Cancer Research. 21(10). 2348–2358. 59 indexed citations

12.

Krivtsov, Andrei V., María E. Figueroa, Amit Sinha, et al.. (2012). Cell of origin determines clinically relevant subtypes of MLL-rearranged AML. Leukemia. 27(4). 852–860. 150 indexed citations

13.

Stubbs, Matthew C. & Scott A. Armstrong. (2007). FLT3 as a Therapeutic Target in Childhood Acute Leukemia. Current Drug Targets. 8(6). 703–714. 11 indexed citations

14.

Stubbs, Matthew C., Yong‐Mi Kim, Andrei V. Krivtsov, et al.. (2007). MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment. Leukemia. 22(1). 66–77. 81 indexed citations

15.

Krivtsov, Andrei V., David Twomey, Zhaohui Feng, et al.. (2006). Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9. Nature. 442(7104). 818–822. 1047 indexed citations breakdown →

16.

Chung, Yuen‐Li, Helen Troy, Ian Judson, et al.. (2003). Pharmacokinetic measurements of a 5FU pro-drug, capecitabine, in bladder tumours over-expressing thymidine phosphorylase. Clinical Cancer Research. 9. 2 indexed citations

17.

Stubbs, Matthew C. & David J. Hall. (2002). The amino-terminus of the E2F-1 transcription factor inhibits DNA replication of autonomously replicating plasmids in mammalian cells. Oncogene. 21(23). 3715–3726. 4 indexed citations

18.

Stubbs, Matthew C., et al.. (2000). The ZF87/MAZ transcription factor functions as a growth suppressor in fibroblasts. Biochemistry and Cell Biology. 78(4). 477–485. 6 indexed citations

19.

Izzo, Marc W., et al.. (1999). Transcriptional Repression from the c-myc P2 Promoter by the Zinc Finger Protein ZF87/MAZ. Journal of Biological Chemistry. 274(27). 19498–19506. 42 indexed citations

20.

Stubbs, Matthew C., et al.. (1999). An Early S Phase Checkpoint Is Regulated by the E2F1 Transcription Factor. Biochemical and Biophysical Research Communications. 258(1). 77–80. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact